| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,879,024 | 1,944,289 | 2,411,479 | 3,056,371 | | Cost of Revenue | 1,379,284 | 1,415,259 | 1,719,177 | 2,123,189 | | | Gross Profit | 499,740 | 529,030 | 692,302 | 933,182 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 398,441 | 395,726 | 450,624 | 502,425 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 101,299 | 133,304 | 241,678 | 430,757 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 581 | 729 | 358 | 994 | | Earnings Before Interest And Taxes | 101,880 | 134,033 | 242,036 | 431,751 | | Interest Expense | 40,479 | 42,803 | 27,524 | 33,051 | | Income Before Tax | 61,401 | 91,230 | 214,512 | 398,700 | | Income Tax Expense | 17,673 | 27,957 | 70,318 | 130,281 | | Minority Interest | (122,839) |
-
|
-
| (69,242) | | | | Net Income From Continuing Ops | (79,111) | 63,273 | 144,194 | 199,177 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (79,111) | 63,273 | 144,194 | 199,177 | | Preferred Stock And Other Adjustments | 86,146 | (38,887) | (47,259) |
-
| | | Net Income Applicable To Common Shares | $7,035 | $24,386 | $96,935 | $199,177 |
|
0.01% Nasdaq 
0.22%
Income Statement
